Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 70 Rectal Neoplasms 29 Colonic Neoplasms 28 Carcinoma, Hepatocellular 26 Neoplasm Metastasis 15 Stomach Neoplasms 12 Pancreatic Neoplasms 7 Cholangiocarcinoma 6 Adenocarcinoma Of Esophagus 6 Esophageal Neoplasms 5 Recurrence 4 Liver Neoplasms 4 Biliary Tract Neoplasms 4 Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Peritoneal Neoplasms 2 Neoplastic Cells, Circulating 2 Gastrointestinal Neoplasms 2 Colorectal Cancer Metastatic 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Adenocarcinoma 2 Postoperative Complications 1 Peripheral Nervous System Diseases 1 Pathologic Complete Response 1 Pancreatic Adenocarcinoma 1 Operable T2-3N+M0 Rectal Cancer (Stage III) 1 Oligometastatic Gastric Adenocarcinoma 1 Neurotoxicity Syndromes 1 Neuropathy, Painful 1 Neuralgia 1

Interventions

Microscopy, Confocal 2 Indocyanine Green 2 Ultrasonography 1 Tumor Burden 1 Sunitinib 1 Simvastatin 1 Radiosurgery 1 Palliative Care 1 Observation 1 Neoadjuvant Therapy 1 Narrow Band Imaging 1 Mastectomy, Segmental 1 IFL protocol 1 Gastrectomy 1 Folfox protocol 1 Everolimus 1 Esophagectomy 1 Endoscopic Mucosal Resection 1 Drug Delivery Systems 1 Drug Combinations 1 Dermoscopy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Margins of Excision × Folfox protocol × Clear all

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡